Human Reproduction, Vol. 15, No. 1, 197-202,
January 2000
© 2000 European Society of Human Reproduction and Embryology
Association between idiopathic premature ovarian failure and fragile X premutation
1 Department of Biology and Genetics for Medical Sciences, University of Milan, Via Viotti 3/5, 20133 Milan, 2 First Department of Obstetrics and Gynaecology, University of Milan, 3 Department of Clinical and Biological Sciences, Ospedale di Circolo, Varese, and 4 Obstetrics and Gynaecology Unit, Department of Clinical and Biological Sciences, University of Insubria, Varese, and 5 Faculty of Medicine, Ospedale San Gerardo, University of Milan-Bicocca, Monza, Italy
A total of 106 women affected by premature ovarian failure (POF) were evaluated for fragile X (FRAXA) premutation. The POF patients were classified as having a familial condition (33 women), at least one relative with early menopause (12 women), or a sporadic condition (61 women). The FRAXA premutation was only detected in patients with familial (four out of 33) or sporadic POF (two out of 61). In general, the results obtained indicated that the prevalence [six out of 106, 6%, 95% confidence interval (CI) 311%] of FRAXA premutation is significantly higher in women affected by POF than expected (P = 1.24x103), suggesting a phenotype consequence of the premutation alleles. This relationship is more convincingly derived from the observation in two analysed pedigrees of a co-segregation between FRAXA and POF. These findings suggest a possible involvement of premutated alleles in ovarian failure, and indicate the utility of POF families screening for FRAXA premutation in order to prevent the transmission of mental retardation syndrome.
Key words: CGG expansion/FMR1 gene/fragile X syndrome/FRAXA premutation/premature ovarian failure
6 To whom correspondence should be addressed
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. Vujovic Aetiology of premature ovarian failure Menopause Int, June 1, 2009; 15(2): 72 - 75. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Z. Zhao, J. N. Painter, J. S. Palmer, P. M. Webb, N. K. Hayward, D. C. Whiteman, D. I. Boomsma, N. G. Martin, D. L. Duffy, and G. W. Montgomery Variation in bone morphogenetic protein 15 is not associated with spontaneous human dizygotic twinning Hum. Reprod., October 1, 2008; 23(10): 2372 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rohr, E.G. Allen, K. Charen, J. Giles, W. He, C. Dominguez, and S.L. Sherman Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study Hum. Reprod., May 1, 2008; 23(5): 1220 - 1225. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.G. Allen, A.K. Sullivan, M. Marcus, C. Small, C. Dominguez, M.P. Epstein, K. Charen, W. He, K.C. Taylor, and S.L. Sherman Examination of reproductive aging milestones among women who carry the FMR1 premutation Hum. Reprod., August 1, 2007; 22(8): 2142 - 2152. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kraff, H.-T. Tang, R. Cilia, M. Canesi, G. Pezzoli, S. Goldwurm, P. J. Hagerman, and F. Tassone Screen for Excess FMR1 Premutation Alleles Among Males With Parkinsonism Arch Neurol, July 1, 2007; 64(7): 1002 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tassone, A. Beilina, C. Carosi, S. Albertosi, C. Bagni, L. Li, K. Glover, D. Bentley, and P. J. Hagerman Elevated FMR1 mRNA in premutation carriers is due to increased transcription RNA, April 1, 2007; 13(4): 555 - 562. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Burlet, N. Frydman, N. Gigarel, V. Kerbrat, G. Tachdjian, E. Feyereisen, J.-P. Bonnefont, R. Frydman, A. Munnich, and J. Steffann Multiple displacement amplification improves PGD for fragile X syndrome Mol. Hum. Reprod., October 1, 2006; 12(10): 647 - 652. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Bodega, S. Bione, L. Dalpra, D. Toniolo, F. Ornaghi, W. Vegetti, E. Ginelli, and A. Marozzi Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation Hum. Reprod., April 1, 2006; 21(4): 952 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Feyereisen, A. Amar, V. Kerbrat, J. Steffann, A. Munnich, M. Vekemans, R. Frydman, and N. Frydman Myotonic dystrophy: does it affect ovarian follicular status and responsiveness to controlled ovarian stimulation? Hum. Reprod., January 1, 2006; 21(1): 175 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lespinasse, P. Hoffmann, A. Lauge, D. Stoppa-Lyonnet, F. Felmann, J.C. Pons, and G. Lesca Chromosomal instability in two siblings with gonad deficiency: Case report Hum. Reprod., January 1, 2005; 20(1): 158 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sereepapong, P. Chotnopparatpattara, S. Taneepanichskul, R. Markham, P. Russell, and I. S. Fraser Endometrial progesterone and estrogen receptors and bleeding disturbances in depot medroxyprogesterone acetate users Hum. Reprod., March 1, 2004; 19(3): 547 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gersak, H. Meden-Vrtovec, and B. Peterlin Fragile X premutation in women with sporadic premature ovarian failure in Slovenia Hum. Reprod., August 1, 2003; 18(8): 1637 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Platteau, K. Sermon, S. Seneca, A. Van Steirteghem, P. Devroey, and I. Liebaers Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible Hum. Reprod., November 1, 2002; 17(11): 2807 - 2812. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hickey and I.S. Fraser Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding Hum. Reprod., September 1, 2002; 17(9): 2428 - 2434. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Martin, G. Cassidy, F. Ahmad, and M. S. Martin Women with Learning Disabilities and the Menopause J Intellect Disabil., June 1, 2001; 5(2): 121 - 132. [Abstract] [PDF] |
||||
![]() |
R. D.L. Hundscheid, D. D.M. Braat, L. A.L.M. Kiemeney, A. P.T. Smits, and C. M.G. Thomas Increased serum FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives Hum. Reprod., March 1, 2001; 16(3): 457 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Rychlik Regarding recall bias in the association between idiopathic premature ovarian failure and fragile X premutation Hum. Reprod., August 1, 2000; 15(8): 1874 - 1874. [Full Text] [PDF] |
||||
![]() |
A. Marozzi Hum. Reprod., August 1, 2000; 15(8): 1874 - 1875. [Full Text] [PDF] |
||||





